Pharmamarketeer

Latest articles

Sanofi announces positive phase 3 data for Dupixent

Sanofi has announced positive phase 3 data showing that nearly three times as many Dupixent patients experienced lower rates of itching and skin lesions at 24 weeks compared to the placebo. Detailed positive results...

contentmarketing

LinkedIn for Content Marketing: 3 Things You Should Know

While LinkedIn is primarily a B2B social media platform, both B2B and B2C brands can benefit from it. Executives from Virgin, GE, and Microsoft all publish on LinkedIn. Here’s what you and your brand should know...

Medhc-fases-banner
Advertentie(s)